Charles Robertson
Concepts (525)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 44 | 2024 | 760 | 3.550 |
Why?
| | Gastrointestinal Microbiome | 31 | 2025 | 699 | 2.610 |
Why?
| | RNA, Ribosomal, 16S | 45 | 2024 | 554 | 1.640 |
Why?
| | Bacteria | 31 | 2023 | 868 | 1.530 |
Why?
| | Intestinal Mucosa | 11 | 2025 | 620 | 0.940 |
Why?
| | Otitis Media | 6 | 2025 | 167 | 0.930 |
Why?
| | Cystic Fibrosis | 12 | 2023 | 1100 | 0.870 |
Why?
| | Feces | 17 | 2025 | 481 | 0.800 |
Why?
| | Intestines | 9 | 2017 | 356 | 0.740 |
Why?
| | Metagenome | 10 | 2019 | 149 | 0.720 |
Why?
| | Nasopharynx | 5 | 2024 | 72 | 0.660 |
Why?
| | Biodiversity | 11 | 2020 | 414 | 0.630 |
Why?
| | Rhinitis | 6 | 2020 | 171 | 0.630 |
Why?
| | Water Microbiology | 8 | 2018 | 85 | 0.630 |
Why?
| | Sinusitis | 6 | 2020 | 237 | 0.590 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 84 | 0.540 |
Why?
| | Colon | 4 | 2025 | 284 | 0.520 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 141 | 0.510 |
Why?
| | Phylogeny | 13 | 2020 | 1000 | 0.510 |
Why?
| | Air Microbiology | 2 | 2015 | 47 | 0.500 |
Why?
| | Archaea | 2 | 2008 | 84 | 0.500 |
Why?
| | Ileum | 4 | 2020 | 109 | 0.480 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 824 | 0.470 |
Why?
| | Breast Feeding | 6 | 2025 | 434 | 0.460 |
Why?
| | RNA, Bacterial | 8 | 2018 | 188 | 0.430 |
Why?
| | Database Management Systems | 1 | 2013 | 51 | 0.410 |
Why?
| | Computer Graphics | 1 | 2013 | 42 | 0.410 |
Why?
| | Railroads | 1 | 2013 | 6 | 0.400 |
Why?
| | User-Computer Interface | 1 | 2013 | 163 | 0.380 |
Why?
| | Aerosols | 1 | 2013 | 181 | 0.370 |
Why?
| | Geologic Sediments | 2 | 2008 | 46 | 0.360 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 108 | 0.360 |
Why?
| | Trachea | 4 | 2023 | 255 | 0.360 |
Why?
| | Colitis | 3 | 2025 | 266 | 0.350 |
Why?
| | HIV Infections | 5 | 2025 | 2945 | 0.340 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 144 | 0.340 |
Why?
| | Inflammation | 11 | 2025 | 2853 | 0.330 |
Why?
| | Crohn Disease | 4 | 2020 | 250 | 0.330 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.330 |
Why?
| | Dysbiosis | 5 | 2023 | 180 | 0.310 |
Why?
| | DNA, Bacterial | 8 | 2021 | 336 | 0.310 |
Why?
| | Humans | 80 | 2025 | 138972 | 0.310 |
Why?
| | Lung | 7 | 2021 | 4103 | 0.310 |
Why?
| | Genes, rRNA | 5 | 2015 | 42 | 0.290 |
Why?
| | Software | 1 | 2013 | 670 | 0.280 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 264 | 0.280 |
Why?
| | Male | 53 | 2025 | 68250 | 0.280 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 177 | 0.270 |
Why?
| | Case-Control Studies | 15 | 2020 | 3574 | 0.270 |
Why?
| | Female | 54 | 2025 | 74016 | 0.270 |
Why?
| | Mice | 23 | 2025 | 17828 | 0.260 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 9 | 0.260 |
Why?
| | Bronchoalveolar Lavage Fluid | 4 | 2021 | 649 | 0.260 |
Why?
| | Animals | 32 | 2025 | 37243 | 0.250 |
Why?
| | Legionella | 2 | 2017 | 7 | 0.250 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 217 | 0.250 |
Why?
| | HIV-1 | 2 | 2024 | 886 | 0.240 |
Why?
| | Dietary Supplements | 3 | 2019 | 559 | 0.240 |
Why?
| | Fatty Liver | 2 | 2021 | 230 | 0.240 |
Why?
| | Drinking Water | 3 | 2017 | 84 | 0.240 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 190 | 0.240 |
Why?
| | Blueberry Plants | 1 | 2025 | 7 | 0.240 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2925 | 0.240 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 221 | 0.240 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 58 | 0.240 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 34 | 0.230 |
Why?
| | Environmental Microbiology | 1 | 2005 | 53 | 0.230 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 325 | 0.230 |
Why?
| | Drug Resistance | 2 | 2017 | 149 | 0.230 |
Why?
| | Ear, Middle | 5 | 2025 | 84 | 0.230 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 37 | 0.220 |
Why?
| | Construction Materials | 2 | 2015 | 16 | 0.220 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 169 | 0.220 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 137 | 0.220 |
Why?
| | Pentanols | 1 | 2024 | 5 | 0.220 |
Why?
| | Lyases | 1 | 2024 | 14 | 0.220 |
Why?
| | Metagenomics | 3 | 2019 | 177 | 0.220 |
Why?
| | Bacteremia | 2 | 2018 | 214 | 0.220 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 433 | 0.210 |
Why?
| | Liver | 3 | 2020 | 1807 | 0.210 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2017 | 543 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 108 | 0.210 |
Why?
| | Ecosystem | 2 | 2007 | 573 | 0.210 |
Why?
| | Adult | 30 | 2025 | 38393 | 0.210 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5801 | 0.210 |
Why?
| | Infant Formula | 2 | 2023 | 73 | 0.210 |
Why?
| | Butyrates | 1 | 2024 | 60 | 0.210 |
Why?
| | Sputum | 5 | 2020 | 305 | 0.210 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3705 | 0.210 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 496 | 0.210 |
Why?
| | Child | 22 | 2025 | 21936 | 0.210 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 383 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 110 | 0.210 |
Why?
| | Respiratory System | 2 | 2016 | 157 | 0.200 |
Why?
| | Diet, Western | 2 | 2022 | 81 | 0.200 |
Why?
| | Premature Birth | 3 | 2017 | 343 | 0.200 |
Why?
| | Milk, Human | 3 | 2023 | 153 | 0.200 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 563 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2025 | 227 | 0.200 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 266 | 0.190 |
Why?
| | Staphylococcus | 4 | 2017 | 75 | 0.190 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 151 | 0.190 |
Why?
| | Iron | 2 | 2016 | 324 | 0.190 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 347 | 0.190 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.190 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1165 | 0.190 |
Why?
| | Hypersensitivity | 1 | 2025 | 254 | 0.190 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.190 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1811 | 0.190 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 203 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 386 | 0.180 |
Why?
| | Infant | 12 | 2025 | 9577 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 41 | 0.180 |
Why?
| | Transcriptome | 3 | 2021 | 966 | 0.170 |
Why?
| | Diet | 3 | 2025 | 1285 | 0.170 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 387 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 198 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.170 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.170 |
Why?
| | Oropharynx | 2 | 2024 | 45 | 0.170 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.170 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 5530 | 0.170 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 55 | 0.170 |
Why?
| | Groundwater | 1 | 2020 | 39 | 0.160 |
Why?
| | Perilipin-2 | 2 | 2017 | 41 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 257 | 0.160 |
Why?
| | Mucin 5AC | 1 | 2020 | 70 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 61 | 0.160 |
Why?
| | Hot Springs | 2 | 2012 | 9 | 0.160 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.160 |
Why?
| | Birth Weight | 2 | 2020 | 515 | 0.160 |
Why?
| | Respiratory System Agents | 1 | 2020 | 23 | 0.160 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 168 | 0.160 |
Why?
| | Biofilms | 3 | 2017 | 266 | 0.160 |
Why?
| | Inflammation Mediators | 2 | 2020 | 513 | 0.160 |
Why?
| | Adolescent | 18 | 2021 | 21581 | 0.150 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 387 | 0.150 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4316 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 21 | 0.150 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.150 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 141 | 0.150 |
Why?
| | Middle Aged | 21 | 2024 | 33782 | 0.150 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 1047 | 0.150 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.150 |
Why?
| | Vitamin B Complex | 1 | 2019 | 41 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 177 | 0.150 |
Why?
| | Diet, High-Fat | 2 | 2017 | 247 | 0.150 |
Why?
| | Chronic Disease | 7 | 2022 | 1804 | 0.150 |
Why?
| | Burns | 1 | 2023 | 340 | 0.150 |
Why?
| | Asthma | 3 | 2017 | 1893 | 0.150 |
Why?
| | Oxonic Acid | 1 | 2018 | 8 | 0.150 |
Why?
| | Biomarkers | 6 | 2025 | 4095 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2362 | 0.150 |
Why?
| | Body Mass Index | 4 | 2020 | 2390 | 0.140 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 9 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 45 | 0.140 |
Why?
| | Vitamin B 12 | 1 | 2019 | 125 | 0.140 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 15 | 0.140 |
Why?
| | Corrosion | 2 | 2015 | 14 | 0.140 |
Why?
| | Chloramines | 2 | 2015 | 11 | 0.140 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 16 | 0.140 |
Why?
| | Quinolones | 1 | 2020 | 135 | 0.140 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 279 | 0.140 |
Why?
| | Probiotics | 1 | 2018 | 56 | 0.140 |
Why?
| | Aminophenols | 1 | 2020 | 158 | 0.140 |
Why?
| | Immunity, Innate | 3 | 2019 | 825 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.140 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 12 | 0.130 |
Why?
| | Infant, Newborn | 8 | 2025 | 6158 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 449 | 0.130 |
Why?
| | Clostridium Infections | 1 | 2018 | 72 | 0.130 |
Why?
| | Sepsis | 1 | 2023 | 611 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 483 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 549 | 0.130 |
Why?
| | Child, Preschool | 9 | 2025 | 11158 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 346 | 0.130 |
Why?
| | Pharynx | 1 | 2016 | 61 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 322 | 0.120 |
Why?
| | Pedigree | 3 | 2025 | 510 | 0.120 |
Why?
| | Respiration, Artificial | 3 | 2023 | 670 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 123 | 0.120 |
Why?
| | Lipid Metabolism | 2 | 2020 | 523 | 0.120 |
Why?
| | Rivers | 1 | 2016 | 64 | 0.120 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 18 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 9 | 0.120 |
Why?
| | Young Adult | 11 | 2021 | 13371 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 79 | 0.120 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 59 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Mice, Knockout | 5 | 2025 | 3029 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 301 | 0.120 |
Why?
| | Cytokines | 3 | 2025 | 2083 | 0.120 |
Why?
| | Lactobacillus | 3 | 2022 | 29 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 21 | 0.120 |
Why?
| | Base Sequence | 3 | 2015 | 2176 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Nose | 1 | 2015 | 65 | 0.120 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 159 | 0.110 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 64 | 0.110 |
Why?
| | Health Facilities | 1 | 2015 | 86 | 0.110 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 39 | 0.110 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.110 |
Why?
| | Bronchi | 1 | 2016 | 269 | 0.110 |
Why?
| | Biota | 1 | 2015 | 35 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 46 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 27 | 0.110 |
Why?
| | Prospective Studies | 7 | 2022 | 7661 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 216 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 242 | 0.110 |
Why?
| | Rats | 6 | 2023 | 5591 | 0.110 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 121 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 621 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 611 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 135 | 0.110 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 63 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 28 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 44 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 32 | 0.100 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 48 | 0.100 |
Why?
| | Age Factors | 2 | 2019 | 3276 | 0.100 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 105 | 0.100 |
Why?
| | Nasal Cavity | 1 | 2013 | 57 | 0.100 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 90 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 990 | 0.100 |
Why?
| | Cities | 1 | 2013 | 132 | 0.100 |
Why?
| | Autoantibodies | 2 | 2018 | 1457 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 24 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 792 | 0.100 |
Why?
| | Soil Microbiology | 1 | 2015 | 209 | 0.100 |
Why?
| | Computational Biology | 2 | 2019 | 650 | 0.100 |
Why?
| | Saliva | 1 | 2015 | 240 | 0.100 |
Why?
| | Hippocampus | 1 | 2018 | 929 | 0.100 |
Why?
| | Aged | 11 | 2023 | 24172 | 0.100 |
Why?
| | New York City | 1 | 2013 | 89 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 63 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 105 | 0.100 |
Why?
| | Iron, Dietary | 1 | 2013 | 22 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 597 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2019 | 1149 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 118 | 0.100 |
Why?
| | Prednisone | 1 | 2013 | 226 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 348 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 593 | 0.100 |
Why?
| | Infant Food | 1 | 2013 | 64 | 0.100 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 242 | 0.100 |
Why?
| | Seawater | 1 | 2012 | 31 | 0.100 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 234 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 16 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 241 | 0.090 |
Why?
| | Bacterial Infections | 1 | 2014 | 245 | 0.090 |
Why?
| | Pregnancy | 6 | 2025 | 6870 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 239 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 31 | 0.090 |
Why?
| | Mexico | 2 | 2012 | 232 | 0.090 |
Why?
| | Bacterial Translocation | 1 | 2012 | 44 | 0.090 |
Why?
| | Body Fluids | 1 | 2012 | 70 | 0.090 |
Why?
| | Islets of Langerhans | 2 | 2015 | 792 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 140 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2011 | 36 | 0.090 |
Why?
| | Autoimmunity | 2 | 2015 | 904 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1467 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 271 | 0.080 |
Why?
| | Esophagus | 1 | 2012 | 257 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1124 | 0.080 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 403 | 0.080 |
Why?
| | Phenotype | 5 | 2020 | 3143 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 428 | 0.080 |
Why?
| | Genes, Bacterial | 3 | 2018 | 166 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 2994 | 0.080 |
Why?
| | Indoles | 1 | 2013 | 411 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 84 | 0.080 |
Why?
| | Genotype | 4 | 2019 | 1849 | 0.080 |
Why?
| | Cholesterol | 2 | 2022 | 403 | 0.080 |
Why?
| | Cohort Studies | 5 | 2019 | 5744 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 348 | 0.080 |
Why?
| | Pacific Ocean | 1 | 2008 | 8 | 0.080 |
Why?
| | RNA, Archaeal | 1 | 2008 | 11 | 0.080 |
Why?
| | DNA, Archaeal | 1 | 2008 | 17 | 0.070 |
Why?
| | Weight Loss | 1 | 2014 | 783 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 156 | 0.070 |
Why?
| | Firmicutes | 2 | 2021 | 19 | 0.070 |
Why?
| | Exome | 2 | 2020 | 237 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2516 | 0.070 |
Why?
| | Smoke | 2 | 2023 | 145 | 0.070 |
Why?
| | Methane | 2 | 2020 | 48 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 766 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 68 | 0.070 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 10 | 0.070 |
Why?
| | Fatty Acids | 2 | 2022 | 445 | 0.070 |
Why?
| | Models, Statistical | 1 | 2011 | 665 | 0.060 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 61 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2025 | 1949 | 0.060 |
Why?
| | Freezing | 1 | 2007 | 88 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 1045 | 0.060 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 13 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 984 | 0.060 |
Why?
| | Equipment Contamination | 2 | 2017 | 71 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2010 | 737 | 0.060 |
Why?
| | Genes, Archaeal | 1 | 2005 | 6 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2020 | 349 | 0.060 |
Why?
| | Cryopreservation | 1 | 2007 | 104 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 193 | 0.060 |
Why?
| | Insulin | 1 | 2016 | 2447 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 113 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 1068 | 0.060 |
Why?
| | Hexanols | 1 | 2024 | 4 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 695 | 0.060 |
Why?
| | Fruit | 1 | 2025 | 146 | 0.060 |
Why?
| | Water Purification | 2 | 2017 | 151 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2591 | 0.050 |
Why?
| | Methylamines | 1 | 2024 | 34 | 0.050 |
Why?
| | Treatment Outcome | 5 | 2020 | 10921 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 199 | 0.050 |
Why?
| | Disinfection | 2 | 2017 | 126 | 0.050 |
Why?
| | Gestational Age | 2 | 2017 | 918 | 0.050 |
Why?
| | Administration, Oral | 2 | 2019 | 787 | 0.050 |
Why?
| | Tobramycin | 1 | 2023 | 52 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2018 | 2815 | 0.050 |
Why?
| | Geography | 2 | 2014 | 200 | 0.050 |
Why?
| | Choline | 1 | 2024 | 131 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 7685 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 557 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1497 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 119 | 0.050 |
Why?
| | Colorado | 3 | 2020 | 4543 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 37 | 0.050 |
Why?
| | Azithromycin | 1 | 2023 | 97 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 61 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 55 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 855 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 77 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2687 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1274 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 226 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 183 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2791 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 10 | 0.050 |
Why?
| | Water | 2 | 2018 | 461 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 265 | 0.050 |
Why?
| | Administration, Inhalation | 1 | 2023 | 595 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2017 | 1192 | 0.050 |
Why?
| | Gastritis | 1 | 2022 | 110 | 0.040 |
Why?
| | Multigene Family | 2 | 2012 | 200 | 0.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 56 | 0.040 |
Why?
| | Enteritis | 1 | 2022 | 104 | 0.040 |
Why?
| | Endoscopy | 2 | 2015 | 320 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2850 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 666 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 459 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 22 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2030 | 0.040 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 593 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 769 | 0.040 |
Why?
| | Bacterial Proteins | 2 | 2018 | 898 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 220 | 0.040 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 32 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 218 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 699 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 96 | 0.040 |
Why?
| | Smoking | 2 | 2020 | 1610 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 215 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 87 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2879 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 539 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 47 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 116 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 366 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 10 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 139 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 73 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 57 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 488 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 183 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 55 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 126 | 0.040 |
Why?
| | Environmental Monitoring | 1 | 2020 | 365 | 0.030 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 106 | 0.030 |
Why?
| | Risk Factors | 3 | 2017 | 10385 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 362 | 0.030 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2017 | 37 | 0.030 |
Why?
| | Prognosis | 2 | 2020 | 3995 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 14 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 96 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2018 | 104 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 42 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 70 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 165 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 453 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 488 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 66 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 201 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1261 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 90 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 6 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 614 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 77 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 836 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 67 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 183 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 335 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 26 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 139 | 0.030 |
Why?
| | Bacillus | 1 | 2015 | 16 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 624 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 731 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 109 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 255 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3636 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 134 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 195 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 78 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 1021 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 30 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 31 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 188 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 70 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 122 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 131 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 524 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 871 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 22 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 41 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 16 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 32 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1441 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 49 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 161 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 209 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 49 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 43 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 92 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 122 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 193 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 492 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 99 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 263 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2047 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 63 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 33 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 2138 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 517 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1487 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 350 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 147 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 317 | 0.030 |
Why?
| | Connectome | 1 | 2014 | 87 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 95 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 213 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 411 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 538 | 0.020 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.020 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.020 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1765 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 42 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 345 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 344 | 0.020 |
Why?
| | DNA, Viral | 1 | 2014 | 365 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1857 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 277 | 0.020 |
Why?
| | Neural Pathways | 1 | 2014 | 303 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 9 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 580 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 32 | 0.020 |
Why?
| | Phototrophic Processes | 1 | 2012 | 1 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 313 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 392 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 50 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 55 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 95 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 61 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2849 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1318 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 85 | 0.020 |
Why?
| | Suction | 1 | 2011 | 32 | 0.020 |
Why?
| | Skin | 1 | 2016 | 756 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2012 | 58 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 140 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 346 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 475 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 561 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 996 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 241 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5152 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1103 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 518 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2241 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 396 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 522 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 353 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 200 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 761 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 452 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2752 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 310 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 591 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4182 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1072 | 0.020 |
Why?
| | Risk | 1 | 2011 | 913 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3984 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1746 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 827 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Mining | 1 | 2007 | 19 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1543 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 980 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1438 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 2228 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 660 | 0.010 |
Why?
| | United States | 1 | 2015 | 15074 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 15901 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|